Atrial Fibrillation and Ischemic Heart Disease: How to Combine Antiplatelet and Anticoagulant Therapy, Depending on the Clinical Situation?

Rational Pharmacotherapy in Cardiology - Russian Federation
doi 10.20996/1819-6446-2016-12-2-191-195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Related search

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2016English

Valvular Heart Disease and “Nonvalvular Atrial Fibrillation” Coumadin or a Novel Oral Anticoagulant Variables to Consider

Cardiology: Open Access
2018English

Combined Aspirin and Anticoagulant Therapy in Patients With Atrial Fibrillation

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2016English

Predictors of Survival in Patients With Ischemic Heart Disease Depending on Therapy

Journal of Education, Health and Sport
2020English

Possibilities of Clinical Laboratory Evaluation of Antiplatelet Therapy Effectiveness in Patients With Ischemic Heart Disease

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2013English

How I Manage Anticoagulant Therapy in Older Individuals With Atrial Fibrillation or Venous Thromboembolism

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Educational and Behavioural Interventions for Anticoagulant Therapy in Patients With Atrial Fibrillation

2013English

The Antithrombotic Therapy of Atrial Fibrillation in Patients With Coronary Heart Disease

Russian Open Medical Journal
Medicine
2018English

How to Choose Appropriate Direct Oral Anticoagulant for Patient With Nonvalvular Atrial Fibrillation

Annals of Hematology
MedicineHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy